Armistice Capital’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $10.4M | Sell |
|
|||||
|
2024
Q2 | $14.2M | Sell |
|
|||||
|
2024
Q1 | $21.6M | Sell |
|
|||||
|
2023
Q4 | $19.4M | Sell |
|
|||||
|
2023
Q3 | $23.5M | Buy |
|
|||||
|
2023
Q2 | $43.6M | Buy |
|
|||||
|
2023
Q1 | $81.4M | Sell |
|
|||||
|
2022
Q4 | $96.7M | Buy |
|
|||||
|
2022
Q3 | $107M | Buy |
|
|||||
|
2022
Q2 | $97.8K | Buy |
|
|||||
|
2022
Q1 | $80M | Buy |
|
|||||
|
2021
Q4 | $79M | Sell |
|
|||||
|
2021
Q3 | $104M | Sell |
|
|||||
|
2021
Q2 | $88M | Buy |
|
|||||
|
2021
Q1 | $81.3M | Buy |
|
|||||
|
2020
Q4 | $57.1M | Buy |
|
|||||
|
2020
Q3 | $24M | Buy |
|
|||||
|
2020
Q2 | $16.3M | Sell |
|
|||||
|
2020
Q1 | $29.2M | Buy |
|
|||||
|
2019
Q4 | $24.3M | Sell |
|
|||||
|
2019
Q3 | $34.8M | Buy |
|
|||||
|
2019
Q2 | $32.1M | Buy |
|
|||||
|
2019
Q1 | $35.5M | Sell |
|
|||||
|
2018
Q4 | $35.4M | Buy |
|
|||||
|
2018
Q3 | $39M | Buy |
|
|||||
|
2018
Q2 | $14.4M | Sell |
|
|||||
|
2018
Q1 | $10.7M | Buy |
|
|||||
|
2017
Q4 | $5.16M | Sell |
|
|||||
|
2017
Q3 | $5.05M | Sell |
|
|||||
|
2017
Q2 | $9.5M | Sell |
|
|||||
|
2017
Q1 | $8.38M | Buy |
|
|||||
|
2016
Q4 | $7.64M | Buy |
|
|||||
|
2016
Q3 | $5.64M | Sell |
|
|||||
|
2016
Q2 | $5.29M | Buy |
|